Opus Genetics: Chardan Capital maintains Buy, raises PT to $11 from $9.

jueves, 12 de marzo de 2026, 8:33 am ET1 min de lectura
IRD--

Opus Genetics: Chardan Capital maintains Buy, raises PT to $11 from $9.

Opus Genetics: Chardan Capital maintains Buy, raises PT to $11 from $9.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios